Phase | Measurements |
---|---|
Baseline: 2013–2014 | Questionnaires with sociodemographic information, social determinants of health, health-related behaviours (smoking, alcohol consumption and physical activity), self-reported comorbidities, medication use, history of previous treatment for Chagas disease, signs and symptoms, functional class (Cardiovascular Functional Class Scale)19 and quality of life (WHO-QOL-BREF)20 ECG Blood collection: immunoassays, PCR for T. cruzi, NT-ProBNP |
Follow-up: 2015–2016 | Questionnaires with sociodemographic information, social determinants of health, health-related behaviours, self-reported comorbidities, medication use, signs and symptoms since baseline. Functional class and quality of life Vital status, history of health service utilisation, including hospital admissiona, health literacy (Short Assessment of Health Literacy)21 ECG Echocardiogram Blood collection: NT-ProBNP |
NT-ProBNP, N-terminal of the prohormone brain natriuretic peptide; SaMi-Trop, São Paulo-Minas Gerais Tropical Medicine Research Center; T. cruzi, Trypanosoma cruzi; WHO-QOL-BREF, WHO Quality of Life-BREF.